ANDA 60625, held by Wyeth Ayerst. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 60625 (Omnipen (Ampicillin)), held by Wyeth Ayerst, was not approved, with 0 approved supplements and 0 published complete response letters.
| Omnipen (Ampicillin)100MG/ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Omnipen (Ampicillin)125MG/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Omnipen (Ampicillin)250MG/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Omnipen (Ampicillin)500MG/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters